Shares of Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) gapped up before the market opened on Thursday . The stock had previously closed at $0.51, but opened at $0.54. Ampio Pharmaceuticals shares last traded at $0.61, with a volume of 44343 shares changing hands.

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) last released its earnings results on Tuesday, August 14th. The specialty pharmaceutical company reported $0.05 earnings per share for the quarter.

Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. lifted its position in shares of Ampio Pharmaceuticals by 4.5% during the 3rd quarter. BlackRock Inc. now owns 5,386,426 shares of the specialty pharmaceutical company’s stock valued at $2,738,000 after acquiring an additional 232,889 shares during the period. Russell Investments Group Ltd. bought a new stake in shares of Ampio Pharmaceuticals during the 3rd quarter worth $220,000. Courier Capital LLC lifted its position in shares of Ampio Pharmaceuticals by 2,032.7% during the 3rd quarter. Courier Capital LLC now owns 304,973 shares of the specialty pharmaceutical company’s stock worth $155,000 after buying an additional 290,673 shares during the last quarter. Northern Trust Corp lifted its position in shares of Ampio Pharmaceuticals by 507.8% during the 2nd quarter. Northern Trust Corp now owns 850,903 shares of the specialty pharmaceutical company’s stock worth $1,872,000 after buying an additional 710,911 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of Ampio Pharmaceuticals by 290.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 202,590 shares of the specialty pharmaceutical company’s stock worth $446,000 after buying an additional 150,664 shares during the last quarter.

ILLEGAL ACTIVITY NOTICE: “Ampio Pharmaceuticals (AMPE) Shares Gap Up to $0.54” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.thecerbatgem.com/2018/11/10/ampio-pharmaceuticals-ampe-shares-gap-up-to-0-54.html.

About Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability.

Featured Story: How to Invest in Marijuana Stocks

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.